What assessment and plan should be implemented for a patient presenting for her first prenatal visit?

Assessment and Plan for the First Prenatal Visit

The first prenatal visit should include comprehensive risk assessment, substance use screening with a validated tool, genetic counseling with aneuploidy screening options, laboratory testing for blood type/Rh/anemia, and nutritional supplementation counseling—all delivered through a structured approach that prioritizes early identification of modifiable risk factors.

Risk Assessment and History

Begin by establishing a reproductive life plan and conducting targeted risk assessment 1:

• Reproductive history: Document all prior pregnancy outcomes including fetal loss, preterm birth, low birth weight, birth defects, or infant death—these predict recurrence risk
• Medical conditions: Screen specifically for hypertension, diabetes, autoimmune diseases, thromboembolism, and rheumatic heart disease that affect pregnancy outcomes
• Medication review: Identify FDA pregnancy category X medications (must discontinue) and category D medications (discontinue unless maternal benefits outweigh fetal risks) 1
• Genetic screening: Assess family history, ethnic background, and maternal age to determine need for carrier screening (cystic fibrosis and others based on ethnicity) 2

Substance Use Screening

All pregnant women must be screened for substance use at the first prenatal visit using a validated questionnaire such as the NIDA Quick Screen Tool 3. This is non-negotiable given that:

• 4.7% of pregnant women report illicit substance use in the past month
• Substance use contributes to 15-22% of pregnancy-associated deaths
• Early identification allows for intervention before irreversible harm

Use structured questionnaires (CAGE or T-ACE) to screen for alcohol and tobacco use 1. Biologic testing should only occur with informed consent and when benefits outweigh harms from mandatory reporting 3.

Aneuploidy Screening Options

Offer all women aneuploidy screening with clear counseling about options 2:

For First Trimester Presentation (before 14 weeks):

• First trimester screening (nuchal translucency + PAPP-A + hCG) is the preferred approach with ~70% detection rate for Down syndrome 2
• Nuchal translucency ≥3.5 mm requires detailed anatomic ultrasound and echocardiogram regardless of other screening results 2
• Cell-free DNA screening is an alternative option

For Second Trimester Presentation:

• Quad screen (AFP, hCG, uE3, inhibin-A) at 15-20 weeks 4
• MSAFP screening optimally performed at 16-18 weeks for neural tube defects 4

Critical Point:

Women ≥35 years should still be offered CVS or amniocentesis for definitive diagnosis despite screening availability 2. All women deserve the option of invasive diagnostic testing regardless of age 2.

Laboratory Testing

Obtain at the first visit 5:

• ABO and Rh blood typing (essential for Rh immunoglobulin administration planning)
• Anemia screening (hemoglobin/hematocrit)
• Rubella immunity, hepatitis B, HIV, syphilis (Wassermann test)
• Urinalysis for proteinuria and asymptomatic bacteriuria
• Cervical cancer screening if due per guidelines

Gestational age must be accurately established—first trimester crown-rump length is accurate within 7 days, second trimester biparietal diameter within 10 days. If gestational age changes by ≥2 weeks after ultrasound, reinterpret all screening results 4.

Nutritional Assessment and Supplementation

Evaluate for micronutrient deficiencies and initiate supplementation 6:

Mandatory Supplementation:

• Folic acid 0.4 mg daily starting preconception or immediately at first visit (higher doses may be needed in high-risk women) 6, 1, 5
• Elemental iron 30-60 mg daily (up to 100 mg if deficient); use IV iron in second/third trimester if oral intolerant, but avoid first trimester 6
• Vitamin D if deficient (high prevalence in pregnancy, associated with preeclampsia, preterm birth, low birth weight) 6
• Vitamin B12 assessment and supplementation if deficient 6

Nutritional Counseling:

• Calculate BMI and establish target gestational weight gain per Institute of Medicine guidelines 6
• Recommend "five-a-day" (2 fruits, 3 vegetables) 1
• Refer to dietitian if: BMI <19.8 or >26.0, history of extensive small bowel surgery, or failure to meet weight gain targets 6

Immunizations and Infection Screening

Update immunizations as needed 1:

• Tdap, influenza (safe in pregnancy)
• Hepatitis B, rubella, varicella (if not immune—give postpartum if live vaccines)
• Screen for periodontal disease, urogenital infections, sexually transmitted infections

Health Promotion and Education

Counsel on risky behaviors 1:

• Smoking cessation: Use the "5 A's" approach (Ask, Advise, Assess, Assist, Arrange)
• Alcohol: Complete abstinence (no safe level in pregnancy)
• Seatbelt use: Mandatory counseling
• Avoid douching

Promote breastfeeding through structured educational programs (evidence-based for improving breastfeeding rates) 5.

Common Pitfalls to Avoid

1. Gestational age errors: Always confirm dating with first trimester ultrasound when possible—errors of ≥2 weeks invalidate screening results 4
2. Delayed screening: First trimester screening must occur before 14 weeks; don't miss this window 2
3. Inadequate substance use screening: Using clinical judgment alone misses most cases—validated tools are mandatory 3
4. Forgetting MSAFP: Even women who had first trimester screening or CVS need MSAFP at 16-18 weeks for neural tube defect screening 2
5. Insufficient folic acid: Women at high risk (prior neural tube defect, certain medications) need higher doses than standard 0.4 mg 6

Special Populations

Women with diabetes: Refer for ophthalmologic examination in first trimester with follow-up based on retinopathy severity (gestational diabetes does NOT require eye exam) 7.

Women with inflammatory bowel disease: Assess for folate, iron, B12, and vitamin D deficiencies with appropriate supplementation—may need higher doses than general population 6.